- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Grace C. Wright Envisions Role of Vectra DA in Future RA Guidelines
As more organizations begin to issue guidelines for the treatment of rheumatoid arthritis, they will incorporate recommendations to determine whether a drug is working. One option that can help give effective care and streamline patient managements is the use of the Vectra DA test, explained Grace C. Wright, MD, PhD, clinical associate professor of medicine and attending rheumatologist at New York University Langone Medical Center.
As more organizations begin to issue guidelines for the treatment of rheumatoid arthritis, they will incorporate recommendations to determine whether a drug is working. One option that can help give effective care and streamline patient managements is the use of the Vectra DA test, explained Grace C. Wright, MD, PhD, clinical associate professor of medicine and attending rheumatologist at New York University Langone Medical Center.
Transcript (slightly modified)
Do you think we will see more professional organizations join United Rheumatology in including Vectra DA in guidelines?
It is our hope that we’ll have many such pathways by other organizations, because it really helps to streamline the management of patients, and certainly that is my hope.
Why do you think a test like Vectra DA hasn’t been added to any other guidelines yet?
A lot of organizations are forming now and just creating guidelines for the first time. We have the [American College of Rheumatology] guidelines that really give us this global management, but regionally a lot of groups are starting to find ways to give effective, cost-effective care. And so incorporating personal guidelines, so that physicians can really sort of target how they treat to specific targets and not spend 6 or 9 months on a drug that’s not working. Guidelines are really something that we’re seeing much more commonly created now.
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Strategies for Improving Patient Access to Dermatology Care
March 22nd 2025Elizabeth Jones, MD, FAAD, highlights the persistent issue of insurance companies favoring expensive, newer medications over equally effective generics in dermatology, emphasizing the time-consuming prior authorization process and advocating for patient partnerships and systemic improvements.
Read More
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
